Manufacturing of a clinical scale CD8 TIL product, AGX148, with and without gene silencing of PD-1 using self-delivering RNAi INTASYLTM PH-762

AGX-148 - AgonOx

PH-762 ACT - Phio Pharma

https://jitc.bmj.com/content/10/Suppl_2/A431

Colin Thalhofer 1; Simon Fricker 2; Ryan Montler 1; Elaine Ballinger 1; Nick Morris 1; Jake Moses 1; Dingxue Yan 2; Tarsem Moudgil 3; Bernard Fox 3; Nelson Sanjuan 3; Eric Tran 3; James Cardia 2; Andrew Weinberg 1

Oct 6, 2022